Table of Contents Author Guidelines Submit a Manuscript
Letter to the Editor
Clinical Study
Journal of Immunology Research
Volume 2018, Article ID 6156024, 3 pages
https://doi.org/10.1155/2018/6156024
Letter to the Editor

Response to: Comment on “New Alternatives for Autoimmune Disease Treatments: Physicochemical and Clinical Comparability of Biosimilar Etanercept”

Unidad de Investigación y Desarrollo, Probiomed S.A. de C.V., Cruce de Carreteras Acatzingo-Zumpahuacán S/N, Colonia Los Shiperes, 52400 Tenancingo de Degollado, MEX, Mexico

Correspondence should be addressed to Luis F. Flores-Ortiz; moc.liamg@zitroserolfocfsiul

Received 9 July 2017; Accepted 15 October 2017; Published 21 February 2018

Academic Editor: Ethan M. Shevach

Copyright © 2018 Mariana P. Miranda-Hernández et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Mariana P. Miranda-Hernández, Carlos A. López-Morales, Francisco C. Perdomo-Abúndez, et al., “Response to: Comment on “New Alternatives for Autoimmune Disease Treatments: Physicochemical and Clinical Comparability of Biosimilar Etanercept”,” Journal of Immunology Research, vol. 2018, Article ID 6156024, 3 pages, 2018. https://doi.org/10.1155/2018/6156024.